cancer-treatment
12 stories related to this topic, newest first.
uctoday.com15-Year-Old Alabama Boy Starts Experimental Cancer Treatment After Social Media Post Attracts Support
A 15-year-old boy from Alabama, battling stage four bone cancer for 16 months, began an experimental treatment in California after his plea reached the Trump administration. The administration connected him with the program in Santa Monica. He flew across the country and has star…
The TimesNHS Rolls Out One-Minute Injection for Key Cancer Drug, Cutting Treatment Time
The UK's National Health Service is introducing an injectable form of the immunotherapy drug pembrolizumab, reducing administration time from up to two hours via intravenous drip to under a minute. This change affects treatment for 14 types of cancer and could benefit about 14,00…
ecns.cnTeddi Mellencamp Requested Weight Loss Medication During Stage 4 Cancer Treatment
Teddi Mellencamp discussed on her podcast that she asked doctors for GLP-1 weight loss medication to address steroid-induced weight gain during her Stage 4 cancer battle but was denied. She revealed she was cancer-free in October 2025 after a three-year fight that included multip…
France 24Revolution Medicines' Daraxonrasib Trial Reports 13.2-Month Median Survival in Pancreatic Cancer Patients
Revolution Medicines announced results from a late-stage trial of its experimental oral drug daraxonrasib for pancreatic cancer patients. Patients receiving daraxonrasib had a median overall survival of 13.2 months, compared to 6.7 months for those on standard intravenous cytotox…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Revolution Medicines' Daraxonrasib Succeeds in Phase 3 Trial for Pancreatic Cancer
Revolution Medicines announced that its targeted pill daraxonrasib met primary and secondary endpoints in a Phase 3 trial for metastatic pancreatic cancer patients. The drug extended median survival to 13.2 months compared to 6.7 months with chemotherapy and reduced the risk of d…
StatAllogene Therapeutics Reports CAR-T Treatment Achieves Minimal Residual Disease Negativity in B-Cell Lymphoma Trial
Allogene Therapeutics announced interim results from a Phase 3 clinical trial of its off-the-shelf CAR-T therapy, cema-cel, for patients with B-cell lymphoma. The treatment achieved minimal residual disease negativity in 58% of patients, compared to 16% in the observation group.
National Institutes of Health. / Wikimedia (Public domain)GSK Plans Five Simultaneous Late-Stage Trials for Potential Blockbuster Cancer Drug
GSK Plc announced plans for five concurrent phase 3 trials of a targeted cancer therapy following promising early data. The initiative aims to advance the drug toward potential blockbuster status. The new CEO is leading efforts to revitalize the company's approach to innovation.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)FDA Rejects Cancer Drug Candidate Lifileucel on Second Attempt After Prior Review
The U.S. Food and Drug Administration has rejected the cancer drug candidate lifileucel for the second time. The drug, developed by Iovance Biotherapeutics, targets advanced melanoma. This decision follows an earlier rejection in 2023 and involves issues with manufacturing and da…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Challenges in Targeting Cancer Tumors with Immunotherapies and Viral Proteins
Immunotherapies and viral proteins that induce cell death serve as tools in cancer treatment. These methods face difficulties in selectively targeting tumors without affecting healthy cells. Researchers continue to explore ways to improve precision in such therapies.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Tumor Mutations Often Unidentified, Limiting Use of Advanced Targeted Therapies
Many advanced targeted therapies remain unused because mutations in tumors are not identified through testing. According to STAT News, this gap affects patient treatment options in oncology. The issue highlights challenges in precision medicine implementation.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Many Cancer Patients Not Receiving Genomic Testing Despite Treatment Advances
A report indicates that a significant number of cancer patients are not undergoing genomic testing, which can identify targeted therapies. This testing analyzes tumor DNA to match treatments to specific genetic mutations. The gap persists even as precision medicine options expand…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Woman Describes Personal Transformation from Caregiving for Mother with Cancer
Amanda Cruz cared for her mother during a cancer diagnosis and treatment, an experience that altered her sense of self. Adult caregiving involves significant responsibilities, as highlighted in her account. The story illustrates the emotional and personal impacts of such roles on…